Abstract Details

Title Pharmacological Changes Induced by Administration of PEGylated IFNb -1a in Healthy Volunteers

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 040

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Larisa Miller, PharmD	Larisa Miller, PharmD has received personal compensation for serving as an employee of Alexion Pharmaceuticals, Inc. Larisa Miller, PharmD has received stock or an ownership interest from Alexion Pharmaceutical, Inc.
David C. McCarthy, Jr., MD (VA Boston Healthcare System)	Dr. McCarthy has nothing to disclose.
	No disclosure on file
	No disclosure on file
Jade Gehrking (Mayo Clinic, Neurology Dept)	Jade Gehrking has nothing to disclose.

��ɫ����